These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 32024640

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer.
    Mirlekar B, Michaud D, Searcy R, Greene K, Pylayeva-Gupta Y.
    Cancer Immunol Res; 2018 Sep; 6(9):1014-1024. PubMed ID: 29980536
    [Abstract] [Full Text] [Related]

  • 3. Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer.
    Das S, Shapiro B, Vucic EA, Vogt S, Bar-Sagi D.
    Cancer Res; 2020 Mar 01; 80(5):1088-1101. PubMed ID: 31915130
    [Abstract] [Full Text] [Related]

  • 4. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
    Huang C, Li Z, Li N, Li Y, Chang A, Zhao T, Wang X, Wang H, Gao S, Yang S, Hao J, Ren H.
    Gastroenterology; 2018 Feb 01; 154(3):675-688. PubMed ID: 28989066
    [Abstract] [Full Text] [Related]

  • 5. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma.
    Tang Y, Xu X, Guo S, Zhang C, Tang Y, Tian Y, Ni B, Lu B, Wang H.
    PLoS One; 2014 Feb 01; 9(3):e91551. PubMed ID: 24637664
    [Abstract] [Full Text] [Related]

  • 6. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y, Lu F, Fei Q, Yu X, Xiong P, Yu X, Dang Y, Hou Z, Lin W, Lin X, Zhang Z, Pan M, Huang H.
    J Hematol Oncol; 2019 Nov 27; 12(1):124. PubMed ID: 31771616
    [Abstract] [Full Text] [Related]

  • 7. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
    Pu N, Zhao G, Yin H, Li JA, Nuerxiati A, Wang D, Xu X, Kuang T, Jin D, Lou W, Wu W.
    J Transl Med; 2018 Oct 25; 16(1):294. PubMed ID: 30359281
    [Abstract] [Full Text] [Related]

  • 8. Th17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients.
    Wang D, Yu W, Lian J, Wu Q, Liu S, Yang L, Li F, Huang L, Chen X, Zhang Z, Li A, Liu J, Sun Z, Wang J, Yuan W, Zhang Y.
    J Hematol Oncol; 2020 Jun 05; 13(1):68. PubMed ID: 32503584
    [Abstract] [Full Text] [Related]

  • 9. Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.
    Oweida AJ, Mueller AC, Piper M, Milner D, Van Court B, Bhatia S, Phan A, Bickett T, Jordan K, Proia T, Schulick R, Messersmith WA, Del Chiaro M, Clambey E, Gough MJ, Williams J, Hansen K, Goodman K, Karam SD.
    Cancer Immunol Immunother; 2021 Apr 05; 70(4):989-1000. PubMed ID: 33097963
    [Abstract] [Full Text] [Related]

  • 10. Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice.
    Perusina Lanfranca M, Zhang Y, Girgis A, Kasselman S, Lazarus J, Kryczek I, Delrosario L, Rhim A, Koneva L, Sartor M, Sun L, Halbrook C, Nathan H, Shi J, Crawford HC, Pasca di Magliano M, Zou W, Frankel TL.
    Gastroenterology; 2020 Apr 05; 158(5):1417-1432.e11. PubMed ID: 31843590
    [Abstract] [Full Text] [Related]

  • 11. IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia.
    Pylayeva-Gupta Y, Das S, Handler JS, Hajdu CH, Coffre M, Koralov SB, Bar-Sagi D.
    Cancer Discov; 2016 Mar 05; 6(3):247-55. PubMed ID: 26715643
    [Abstract] [Full Text] [Related]

  • 12. CD40 Agonist Overcomes T Cell Exhaustion Induced by Chronic Myeloid Cell IL-27 Production in a Pancreatic Cancer Preclinical Model.
    Burrack AL, Rollins MR, Spartz EJ, Mesojednik TD, Schmiechen ZC, Raynor JF, Wang IX, Kedl RM, Stromnes IM.
    J Immunol; 2021 Mar 15; 206(6):1372-1384. PubMed ID: 33558374
    [Abstract] [Full Text] [Related]

  • 13. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression.
    Gao HF, Cheng CS, Tang J, Li Y, Chen H, Meng ZQ, Chen Z, Chen LY.
    Aging (Albany NY); 2020 Jan 08; 12(1):502-517. PubMed ID: 31913856
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis.
    Yue C, Shen S, Deng J, Priceman SJ, Li W, Huang A, Yu H.
    Cancer Immunol Res; 2015 Aug 08; 3(8):864-870. PubMed ID: 26025380
    [Abstract] [Full Text] [Related]

  • 17. Class II transactivator-induced MHC class II expression in pancreatic cancer cells leads to tumor rejection and a specific antitumor memory response.
    Ekkirala CR, Cappello P, Accolla RS, Giovarelli M, Romero I, Garrido C, Garcia-Lora AM, Novelli F.
    Pancreas; 2014 Oct 08; 43(7):1066-72. PubMed ID: 24987872
    [Abstract] [Full Text] [Related]

  • 18. PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.
    Soares KC, Rucki AA, Wu AA, Olino K, Xiao Q, Chai Y, Wamwea A, Bigelow E, Lutz E, Liu L, Yao S, Anders RA, Laheru D, Wolfgang CL, Edil BH, Schulick RD, Jaffee EM, Zheng L.
    J Immunother; 2015 Jan 08; 38(1):1-11. PubMed ID: 25415283
    [Abstract] [Full Text] [Related]

  • 19. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.
    Zhang J, Wang YF, Wu B, Zhong ZX, Wang KX, Yang LQ, Wang YQ, Li YQ, Gao J, Li ZS.
    Curr Mol Med; 2017 Jan 08; 17(10):689-698. PubMed ID: 29521231
    [Abstract] [Full Text] [Related]

  • 20. Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming.
    Hundeyin M, Kurz E, Mishra A, Rossi JAK, Liudahl SM, Leis KR, Mehrotra H, Kim M, Torres LE, Ogunsakin A, Link J, Sears RC, Sivagnanam S, Goecks J, Islam KMS, Dolgalev I, Savadkar S, Wang W, Aykut B, Leinwand J, Diskin B, Adam S, Israr M, Gelas M, Lish J, Chin K, Farooq MS, Wadowski B, Wu J, Shah S, Adeegbe DO, Pushalkar S, Vasudevaraja V, Saxena D, Wong KK, Coussens LM, Miller G.
    Cancer Discov; 2019 Sep 08; 9(9):1288-1305. PubMed ID: 31266770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.